Morgan Stanley’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.26M Buy
509,568
+362,236
+246% +$5.16M ﹤0.01% 3744
2025
Q1
$1.91M Buy
147,332
+134,139
+1,017% +$1.74M ﹤0.01% 4624
2024
Q4
$176K Buy
13,193
+12,721
+2,695% +$169K ﹤0.01% 5840
2024
Q3
$2.83K Buy
472
+280
+146% +$1.68K ﹤0.01% 7060
2024
Q2
$632 Buy
192
+154
+405% +$507 ﹤0.01% 7203
2024
Q1
$143 Sell
38
-38
-50% -$143 ﹤0.01% 7341
2023
Q4
$332 Sell
76
-20
-21% -$87 ﹤0.01% 7315
2023
Q3
$400 Sell
96
-748
-89% -$3.12K ﹤0.01% 7332
2023
Q2
$2.95K Sell
844
-1,860
-69% -$6.49K ﹤0.01% 7111
2023
Q1
$10.4K Sell
2,704
-5,437
-67% -$20.9K ﹤0.01% 6876
2022
Q4
$23K Buy
8,141
+1,391
+21% +$3.92K ﹤0.01% 6630
2022
Q3
$14K Sell
6,750
-1,685
-20% -$3.5K ﹤0.01% 6948
2022
Q2
$23K Sell
8,435
-19,636
-70% -$53.5K ﹤0.01% 6923
2022
Q1
$122K Sell
28,071
-2,001
-7% -$8.7K ﹤0.01% 6194
2021
Q4
$129K Sell
30,072
-4,677
-13% -$20.1K ﹤0.01% 6291
2021
Q3
$175K Buy
34,749
+33,159
+2,085% +$167K ﹤0.01% 6069
2021
Q2
$10K Sell
1,590
-644
-29% -$4.05K ﹤0.01% 7226
2021
Q1
$17K Sell
2,234
-16,069
-88% -$122K ﹤0.01% 6777
2020
Q4
$149K Buy
18,303
+13,422
+275% +$109K ﹤0.01% 5736
2020
Q3
$39K Sell
4,881
-5,439
-53% -$43.5K ﹤0.01% 5809
2020
Q2
$56K Buy
10,320
+4,544
+79% +$24.7K ﹤0.01% 5638
2020
Q1
$24K Buy
5,776
+670
+13% +$2.78K ﹤0.01% 5741
2019
Q4
$36K Buy
5,106
+42
+0.8% +$296 ﹤0.01% 5941
2019
Q3
$32K Buy
5,064
+2,800
+124% +$17.7K ﹤0.01% 5873
2019
Q2
$18K Buy
+2,264
New +$18K ﹤0.01% 5967
2019
Q1
Sell
-400
Closed -$2K 6620
2018
Q4
$2K Buy
+400
New +$2K ﹤0.01% 6409